At a glance
- Originator Wyeth
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 07 May 2003 Discontinued for Type-2 diabetes mellitus in USA (unspecified route)
- 19 Oct 2000 Profile reviewed but no significant changes made
- 17 Oct 1995 No-Development-Reported for Type-2 diabetes mellitus in USA (Unknown route)